Edition:
United States

Chemours Co (CC.N)

CC.N on New York Stock Exchange

48.14USD
11 Dec 2017
Change (% chg)

$0.50 (+1.05%)
Prev Close
$47.64
Open
$47.60
Day's High
$48.62
Day's Low
$47.60
Volume
344,061
Avg. Vol
609,797
52-wk High
$58.07
52-wk Low
$20.76

Chart for

About

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and... (more)

Overall

Beta: --
Market Cap(Mil.): $8,803.92
Shares Outstanding(Mil.): 184.80
Dividend: 0.17
Yield (%): 1.43

Financials

  Industry Sector
P/E (TTM): -- 25.62 15.67
EPS (TTM): -- -- --
ROI: -- 16.94 34.62
ROE: -- 21.87 16.00

BRIEF-Chemours Updates 2017 Forecast, Provides 2018 Outlook, 2020 Key Financial Targets

* CHEMOURS CO - BOARD OF DIRECTORS AUTHORIZED A $500 MILLION SHARE REPURCHASE PLAN

Dec 01 2017

BRIEF-Greenlight Capital cuts share stake in Apple, General Motors

* Greenlight Capital cuts share stake in Apple Inc by 44.2 percent to 2.2 million shares - SEC filing

Nov 14 2017

BRIEF-The Chemours Company reports third quarter results

* Q3 earnings per share view $1.04 -- Thomson Reuters I/B/E/S

Nov 02 2017

BRIEF-UTR partners with Chemours to develop anode material

* Co ‍entered into agreement with Chemours to jointly develop anode material Source text for Eikon: Further company coverage:

Oct 25 2017

Ex-Chemours employee accused by U.S. of trade secrets theft scheme

A former Chemours Co employee has been indicted on U.S. charges that he conspired to steal trade secrets related to its lucrative sodium cyanide business and sell them to Chinese investors, U.S. prosecutors said on Thursday.

Oct 12 2017

Ex-Chemours employee accused by U.S. of trade secrets theft scheme

Oct 12 A former Chemours Co employee has been indicted on U.S. charges that he conspired to steal trade secrets related to its lucrative sodium cyanide business and monetize them with Chinese investors, U.S. prosecutors said on Thursday.

Oct 12 2017

BRIEF-Chemours co - ‍ on Aug 4, co, E. I. du Pont de Nemours and company entered into an amendment to separation agreement

* Chemours Co - ‍ on Aug 4, co, E. I. du Pont de Nemours and company entered into an amendment to separation agreement, dated as of July 1, 2015​

Aug 25 2017

BRIEF-Chemours responds to EPA 2015 ruling to regulate HFCs

* Company is currently reviewing court's ruling and assessing its options which could include an appeal of this ruling

Aug 09 2017

BRIEF-The Chemours Company Q2 earnings per share $0.84

* The Chemours Company reports strong second quarter results and increases full-year 2017 outlook

Aug 02 2017

BRIEF-Chemours sees 2017 adjusted EBITDA above $1.25 bln

* Chemours Co - sees 2017 adjusted EBITDA above $1.25 billion

Jun 28 2017

Earnings vs. Estimates